Elbonix 50mg 7s x 4 (28)

$331.20

7s X 4 = 28 tablets, manufacturer: Beacon

Categories: , Tags: , , , ,

Description

Composition Eltrombopag 50 mg
Substitutes Elbonix 50 mg 7s x 5,Revolade 50mg 7s x 2 (FR)
Shipping class Room Temperature

Medicine Overview of Elbonix 50mg 7s

uses

Uses of Elbonix 50mg 7s

Eltrombopag is used for low platelet count due to ITP or HCV infection. It is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It’s also used to treat severe aplastic anemia.
uses

Elbonix 50mg 7s side effects

Common

Nausea, Diarrhoea, Upper respiratory tract infection, Vomiting, Increased liver enzymes, Muscle pain, Urinary tract infection
uses

How to use Elbonix 50mg 7s

Take Eltrombopag on an empty stomach, either 1 hour before or 2 hours after meals.

How Elbonix 50mg 7s works

Eltrombopag is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.

In Depth Information on Elbonix 50mg 7s

Expert advice for Elbonix 50mg 7s

  • Take Eltrombopag at least 2 hours before or 4 hours after eating dairy products and calcium-fortified juices.

Elbonix 50mg 7s related warnings

Special precautions for Elbonix 50mg 7s

alcohol
Alcohol
WEIGH RISKS VS BENEFITS
There is no adequate data. Please consult your doctor.
pregnancy
Pregnancy
WEIGH RISK VS BENEFIT
There are no adequate and well-controlled studies of Eltrombopag use in pregnancy. In animal reproduction and developmental toxicity studies, there was evidence ofembryolethality and reduced fetal weights at maternally toxic doses. Eltrombopag should beused in pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.
lactation
Lactation
It is not known whether Eltrombopag is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Eltrombopag, a decision should be made whether to discontinue nursing or to discontinue Eltrombopag taking into account the importance of Eltrombopag to the mother.
driving
Driving
There is no adequate data. Please consult your doctor.
kidney
Kidney
Hepatic impairment influences the exposure of Eltrombopag. Reduce the initial dose of Eltrombopag in patients with chronic ITP (adult and pediatric patients 6 years and older only) or severe aplastic anemia who also have hepatic impairment (Child-Pugh Class A, B, C). No dosage adjustment is necessary for patients with chronic hepatitis C and hepatic impairment.
liver
Liver
No adjustment in the initial dose of Eltrombopag is needed for patients with renal impairment. Closely monitor patients with impaired renal function when administering Eltrombopag.

What if you miss a dose of Elbonix 50mg 7s?

In case you miss a dose, take the next dose at the next time interval.

Additional information

Weight 0.04 kg